• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development a new glaucoma model and the identification of the factors inducing glaucomatous neuropathy

Research Project

Project/Area Number 14571669
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

TANABE Teruyo  Kyoto University, faculty of Medicine, Lecturer, 医学研究科, 講師 (80243020)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Masayo  Kyoto University, Faculty of Medicine, Associate Professor, 医学研究科, 助教授 (80252443)
田辺 康人  科学技術振興事業団, 若手さきがけ, 専任研究者
柏井 聡  京都大学, 医学研究科, 助教授 (50194717)
本田 孔士  京都大学, 医学研究科, 教授 (90026930)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsGlaucoma model / Optic disc / Microarray / astro cyte / Retinal ganglion cell / Gene transfer / HVJ-envelope vector / 視神経障害 / HVJ-Envelopeベクター
Research Abstract

In this study, we first tried to develop a new glaucoma model rat by transferring the cytotoxic gene to the trabecular meshwork, a main structure in the outflow system of aqueous humor. We employed HVJ envelope vector, a hybrid vector which has been reported to deliver the target gene in an efficient and a safe manner. We injected the HVJ envelope vector, containing the plasmid DNA which is subcloned reporter gene under the CMV promoter, into the anterior chamber of rats. During the period of 4 weeks after injection, there was no significant expression of reporter gene in the trabecular meshwork, compared to control eyes. To find a reliable glaucoma model, we made several kinds of glaucoma model rat and found out that the episcleral vein occulusion could induce chronic ocular hypertension with little surgical damage. Episcleral vein occulusion model showed the 30% decrease in number of retinal ganglion cells(RGCs) at 12 weeks after treatment, and the loss of RGCs and the cupping of optic disc were more significant at 30 weeks after treatment. There observed no gross changes in other retinal neurons, while Muller glia expressed the markers that indicate the reactive condition. During the early phase of IOP elevation, astrocytes within the optic nerve showed the increased expression of caspase 3, a marker for cell death, preceding the decrease in number of astrocytes. Microarray analysis for optic disc at 12 weeks after treatment, revealed that some of the genes involved in the cell adhesion, the formation of extracellular matrix, the regulation of cell cycle, were affected and the intensive study to find the factors to induce glaucomatous neuropathy is underway.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi